Whitehead A M
Medical Department, Duphar Laboratories Ltd., Southampton, England.
Pharm Weekbl Sci. 1988 Feb 19;10(1):12-6. doi: 10.1007/BF01966429.
An in vitro study of currently available pancreatic enzyme preparations was carried out to compare the three main types of product available, these being simple pancreatin preparations, enteric coated tablets and enteric coated granules. Two products from each of these types were analysed to compare their enzyme contents. The enteric coated preparations were tested for acid resistance and their pH dissolution profiles were also investigated. The measured enzyme contents were generally higher than the declared values but products' enzyme declarations remain valid for comparison. As the BP declaration for protease does not include total protease this value may be misleading. Acid resistance and pH dissolution profiles varied both between the types of preparation and between the actual products tested. The enteric coated granule preparations were more resistant to acid and released their enzyme more rapidly once the pH threshold of dissolution was reached. Of the two enteric coated granule preparations, Creon (Duphar) was more resistant to acid and released its enzyme from a slightly lower pH value.
开展了一项关于现有胰酶制剂的体外研究,以比较三种主要类型的产品,即单纯胰酶制剂、肠溶包衣片和肠溶包衣颗粒。从每种类型中选取两种产品进行分析,以比较它们的酶含量。对肠溶包衣制剂进行了耐酸性测试,并研究了它们的pH溶解曲线。测得的酶含量一般高于申报值,但产品的酶申报值仍可用于比较。由于英国药典(BP)对蛋白酶的申报不包括总蛋白酶,该值可能会产生误导。耐酸性和pH溶解曲线在制剂类型之间以及实际测试的产品之间均有所不同。肠溶包衣颗粒制剂对酸更具抗性,一旦达到溶解的pH阈值,其酶释放得更快。在两种肠溶包衣颗粒制剂中,得每通(Creon,杜法尔公司生产)对酸更具抗性,并且在略低的pH值下释放其酶。